Skip to content

Clinical trials

Withdrawn Observational Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Observational Status: Withdrawn Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20082
20101
20111
20152
20161
20171
20182
20191
20201
20224
20232
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center4
AstraZeneca2
Maastricht Radiation Oncology2
Pfizer2
Takeda2
Addario Lung Cancer Medical Institute1
Alliance for Clinical Trials in Oncology1
Centre Hospitalier Universitaire de Nice1
IsoRay Medical, Inc.1
Mark M. Fuster, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung26
Lung Neoplasms10
Small Cell Lung Carcinoma4
Breast Neoplasms2
Neoplasm Metastasis2
Pleural Effusion, Malignant2
Uterine Cervical Neoplasms2
Adenocarcinoma of Lung1
Anus Neoplasms1
Appendiceal Neoplasms1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.